Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Scheel

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|April 21, 2022
Neutralization and receptor use of infectious culture-derived rat hepacivirus as a model for HCVRaphael Wolfisberg, Caroline E Thorselius, Eduardo Salinas, et al.
Cell Host & Microbe|April 1, 2021
Argonaute-CLIP delineates versatile, functional RNAi networks in Aedes aegypti, a major vector of human virusesKathryn Rozen-Gagnon, Meigang Gu, Joseph M Luna, et al.
Oncotarget|April 23, 2016
Twist1 induces distinct cell states depending on TGFBR1-activationDiana Dragoi, Anja Krattenmacher, Vivek K Mishra, et al.
Journal of Virology|March 27, 2023
Molecular Determinants of Mouse Adaptation of Rat HepacivirusRaphael Wolfisberg, Kenn Holmbeck, Eva Billerbeck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLCChristoph Arolt, Margaret Dugan, Robert Wild, et al.
Development (Cambridge, England)|June 14, 2015
Quantification of regenerative potential in primary human mammary epithelial cellsJelena R Linnemann, Haruko Miura, Lisa K Meixner, et al.
NPJ Precision Oncology|November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-scoreChristoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Hepatology (Baltimore, Md.)|April 23, 2024
JFH1-based Core-NS2 genotype variants of HCV with genetic stability in vivo and in vitro: Important tools in the evaluation of virus neutralizationLaura Collignon, Kenn Holmbeck, Ashley Just, et al.
Viruses|February 26, 2022
Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and ReplicationUlrik Fahnøe, Long V Pham, Carlota Fernandez-Antunez, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 <i>In Vitro</i>Karen A Gammeltoft, Yuyong Zhou, Carlos R Duarte Hernandez, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|April 21, 2022
Neutralization and receptor use of infectious culture-derived rat hepacivirus as a model for HCVRaphael Wolfisberg, Caroline E Thorselius, Eduardo Salinas, et al.
Cell Host & Microbe|April 1, 2021
Argonaute-CLIP delineates versatile, functional RNAi networks in Aedes aegypti, a major vector of human virusesKathryn Rozen-Gagnon, Meigang Gu, Joseph M Luna, et al.
Oncotarget|April 23, 2016
Twist1 induces distinct cell states depending on TGFBR1-activationDiana Dragoi, Anja Krattenmacher, Vivek K Mishra, et al.
Journal of Virology|March 27, 2023
Molecular Determinants of Mouse Adaptation of Rat HepacivirusRaphael Wolfisberg, Kenn Holmbeck, Eva Billerbeck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLCChristoph Arolt, Margaret Dugan, Robert Wild, et al.
Development (Cambridge, England)|June 14, 2015
Quantification of regenerative potential in primary human mammary epithelial cellsJelena R Linnemann, Haruko Miura, Lisa K Meixner, et al.
NPJ Precision Oncology|November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-scoreChristoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Hepatology (Baltimore, Md.)|April 23, 2024
JFH1-based Core-NS2 genotype variants of HCV with genetic stability in vivo and in vitro: Important tools in the evaluation of virus neutralizationLaura Collignon, Kenn Holmbeck, Ashley Just, et al.
Viruses|February 26, 2022
Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and ReplicationUlrik Fahnøe, Long V Pham, Carlota Fernandez-Antunez, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 <i>In Vitro</i>Karen A Gammeltoft, Yuyong Zhou, Carlos R Duarte Hernandez, et al.
Pageof 17